Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M G Romantsov

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|November 2, 2010
[Rational pharmacotherapy and correction of immunity disorders in children with chronic hepatitis (clinical review)]L G Goriacheva, M G Romantsov, S G Agaeva, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|October 6, 2010
[Experimental study of cytoprotector effect of succinate-containing drugs on functional activity of liver]D S Sukhanov, A L Kovalenko, M G Romantsov, et al.
Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|January 29, 2013
[Experimental and clinicolaboratory evaluation of complex therapy efficacy in arboviral infections]M G Romantsov, Kh M Galimzianov, O M Lokteva, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|August 16, 2012
[Relationship between the endogenous interferon IFN-gamma level and risk of hepatotoxic liver damage in tuberculosis patients]D S Sukhanov, S V Okovityĭ, S N Demidik, et al.
Pediatriia|October 1, 1982
[Clinico-immunological and epidemiological characteristics of acute viral hepatitis in children in the first 3 years of life]I V Gol'zand, V O Volkov, L G Goriacheva, et al.
Klinicheskaia Meditsina|July 9, 2010
[Efficacy of cytoflavin in the treatment of chronic cerebral ischemia]Z A Suslina, E G Klocheva, M A Piradov, et al.
Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|May 16, 2015
[Induction of type 1, 2 and 3 interferons by acridone acetates]S S Grigoryan, A Yu Petrov, E I Isaeva, et al.
Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|December 8, 2011
[Manifestations of immune deficiency in children with perinatal HIV infection in the treatment dynamics]A G Petrova, E V Moskaleva, S V Smirnova, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|March 22, 2014
[Reamberin optimizes drug therapy in children with acute Epstein-Barr viral infection]E B Kasymova, O A Bashkina, Kh M Galimzianov, et al.
Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|September 15, 2011
[Minimization of endogenous intoxication syndrome by individual choice of drugs for therapy of chronic hepatitis]D K Vasil'eva, L G Goriacheva, M Ia Kotiv, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|November 2, 2010
[Rational pharmacotherapy and correction of immunity disorders in children with chronic hepatitis (clinical review)]L G Goriacheva, M G Romantsov, S G Agaeva, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|October 6, 2010
[Experimental study of cytoprotector effect of succinate-containing drugs on functional activity of liver]D S Sukhanov, A L Kovalenko, M G Romantsov, et al.
Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|January 29, 2013
[Experimental and clinicolaboratory evaluation of complex therapy efficacy in arboviral infections]M G Romantsov, Kh M Galimzianov, O M Lokteva, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|August 16, 2012
[Relationship between the endogenous interferon IFN-gamma level and risk of hepatotoxic liver damage in tuberculosis patients]D S Sukhanov, S V Okovityĭ, S N Demidik, et al.
Pediatriia|October 1, 1982
[Clinico-immunological and epidemiological characteristics of acute viral hepatitis in children in the first 3 years of life]I V Gol'zand, V O Volkov, L G Goriacheva, et al.
Klinicheskaia Meditsina|July 9, 2010
[Efficacy of cytoflavin in the treatment of chronic cerebral ischemia]Z A Suslina, E G Klocheva, M A Piradov, et al.
Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|May 16, 2015
[Induction of type 1, 2 and 3 interferons by acridone acetates]S S Grigoryan, A Yu Petrov, E I Isaeva, et al.
Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|December 8, 2011
[Manifestations of immune deficiency in children with perinatal HIV infection in the treatment dynamics]A G Petrova, E V Moskaleva, S V Smirnova, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|March 22, 2014
[Reamberin optimizes drug therapy in children with acute Epstein-Barr viral infection]E B Kasymova, O A Bashkina, Kh M Galimzianov, et al.
Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|September 15, 2011
[Minimization of endogenous intoxication syndrome by individual choice of drugs for therapy of chronic hepatitis]D K Vasil'eva, L G Goriacheva, M Ia Kotiv, et al.
Pageof 9